查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1714710

避孕药市场：2025-2030 年全球预测，按类型、剂型、作用机制、材料类型、使用期限、使用频率、销售管道、应用和最终用户划分

Contraceptive Market by Type, Formulation, Mode Of Action, Material Type, Duration, Usage Frequency, Sales Channel, Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2024年避孕药市值将达384亿美元，2025年将达411.3亿美元，复合年增长率为7.41%，预计2030年将达589.8亿美元。

主要市场统计数据
基准年2024年 384亿美元
预计年份：2025年 411.3亿美元
预测年份 2030 589.8亿美元
复合年增长率（%） 7.41%

在科技进步和消费者偏好变化的推动下，避孕市场正经历强劲创新和动态演变的时期。近年来，市场参与企业进入了一个对更有效、更方便、更灵活的避孕解决方案的需求不断增长的环境。这种转变的基础是不断发展的卫生政策、日益增强的生殖健康意识以及对研发的大量投资。公司和相关人员现在正在采取优先考虑以患者为中心的方法的策略，创造一个传统方法不断透过变革性突破而增强的环境。

在这种环境下，明智的决策和策略规划发挥着至关重要的作用。当今市场不仅受到技术进步的驱动，也受到影响消费者接受的社会经济变化的推动。全球市场持续扩大，为成长和合作提供了良好的机会，因为主要相关人员努力在创新和可及性之间取得平衡。分析这些方面为理解影响避孕行业的因素的更广泛影响提供了基础。本概述为讨论对于更深入的洞察、策略转变和深入的市场分析至关重要的细分动态奠定了基础。

改变避孕市场

市场最近的变化正在重新定义避孕措施的认知、发展和实施方式。产品技术的创新、对个人需求的更多关注以及产品配方的突破都促使人们从传统方法转向更加多样化的解决方案。主要企业目前正在投资先进研究，以优化剂型并改进输送机制，以满足长期可靠性和短期灵活性的需求。

此外，监管变化和不断发展的医疗框架也大大加快了产品开发週期。加强品管和重视临床效果正在增强消费者信心。市场趋势表明，数推广趋势明显，线上分销管道扩大了资讯和产品的获取管道，最终提高了客户参与。这些动态变化显示市场不再停滞不前，而是不断拥抱创新。这种持续的演变为产品的进一步成长和改进奠定了基础，因此产业领导者必须调整和调整其策略，以在日益活跃的市场中保持竞争力。

关键细分洞察

透过各种细分方法分析市场可以为了解消费行为和发现利基机会提供宝贵的观点。市场按类型研究，分析事后紧急避孕药、荷尔蒙、非荷尔蒙和永久性避孕方法。事后紧急避孕药包括子宫内避孕器和避孕药，而荷尔蒙避孕又进一步分为植入、注射、口服避孕药和经皮避孕药。对非荷尔蒙类别的进一步探索可以深入了解屏障法、草药避孕法和自然法，而草药类别则细分为阿育吠陀疗法和同类疗法疗法。同时，永久性部分具有输卵管结扎和输精管切除选项。

其他维度包括产品剂型，以贴片、药丸和环的形式进行分析，其中药丸进一步分为单相和多相亚型。采用多方面的观点，市场也透过作用机制进行审查，区分抗植入、杀精和抑制排卵等解决方案。此外，我们透过评估乳胶基和非乳胶变化来提供对材料类型的重点洞察。对于后者，腈纶、聚异戊二烯和聚氨酯正在进一步研究。基于持续时间的细分将产品分为长期解决方案和短期解决方案，而基于使用频率的细分则区分按需解决方案和常规使用。分销管道和应用场景进一步细分了这个细分领域，以分析透过医院药房和传统药局等线下场所以及电子商务入口网站和线上药局等线上平台的分销。最后，最终用户分析将市场细分为女性和男性人口统计数据，其中女性细分市场进一步分为青少年、成年人和停经后群体，从而提供消费者人口统计和偏好的全面视角。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章 市场洞察

  • 市场动态
    • 驱动程式
      • 提高消费者对生殖健康和避孕的认识与教育
      • 政府为控制人口而采取的避孕器措施和政策
      • 技术进步促进了更新、更有效的避孕方法的开发
    • 限制因素
      • 在有效避孕方法教育意识提升方面所遇到的障碍
    • 机会
      • 远端医疗的兴起将使偏远地区的消费者和忙碌的消费者更容易获得处方笺
      • 对男性避孕的日益关注为产品创新和多样化创造了新的机会
    • 任务
      • 担心避孕解决方案需要个人化和客製化才能满足多样化需求
      • 解决影响避孕措施接受和采用的社会和文化偏见
  • 市场区隔分析
    • 类型：由于其有效性和易于停药，口服避孕药已成为一种趋势。
    • 最终用户：产品种类繁多，显着提高女性用避孕器的采用率
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章 避孕药市场（依类型）

  • 介绍
  • 事后紧急避孕药
    • 子宫内避孕器
    • 锭剂
  • 荷尔蒙
    • 植入式避孕器
    • 注射避孕药
    • 口服避孕药
    • 经皮避孕药
  • 非荷尔蒙
    • 屏障法
    • 草药避孕药
      • 阿育吠陀
      • 同类疗法
    • 自然的方式
  • 持久性
    • 输卵管结扎
    • 切除术

第七章 避孕药市场（以剂型）

  • 介绍
  • 修补
  • 丸
    • 单相
    • 多态性
  • 戒指

8. 避孕药市场（依作用机转）

  • 介绍
  • 预防植入
  • 杀精作用
  • 抑制排卵

9. 避孕药市场（依材料类型）

  • 介绍
  • 乳胶基底
  • 不含乳胶
    • 腈纶
    • 聚异戊二烯
    • 聚氨酯

第十章 避孕药市场（依使用时长）

  • 介绍
  • 长期
  • 短期

第11章 避孕药具市场（依使用频率）

  • 介绍
  • 一经请求
  • 正常使用

第十二章 避孕药市场（依通路）

  • 介绍
  • 离线
    • 医院药房
    • 药局
  • 在线的
    • 电商平台
    • 网路药局

第十三章 避孕药市场（依应用）

  • 介绍
  • 一般
  • 性交后使用

第十四章 避孕药具市场（依最终用户）

  • 介绍
  • 女士
    • 青春期
    • 对于成年人
    • 停经后
  • 男性

15.美洲避孕药市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

16.亚太避孕市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

17. 欧洲、中东和非洲的避孕药市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十八章竞争格局

  • 2024年市场占有率分析
  • 2024年FPNV定位矩阵
  • 竞争情境分析
  • 战略分析与建议

公司名单

  • Abbvie Inc.
  • Acme Generics Pvt. Ltd.
  • Afaxys, Inc.
  • Agile Therapeutics, Inc.
  • Amneal Pharmaceuticals LLC
  • ASKA Pharmaceutical Co., Ltd.
  • Aurobindo Pharma Limited
  • Bayer AG
  • Church & Dwight Co., Inc.
  • Cipla Limited
  • HLL Lifecare Limited
  • Insud Pharma, SL
  • Johnson & Johnson Services, Inc.
  • Lupin Limited
  • Mayne Pharma Group Limited
  • Merck & Co., Inc.
  • Mithra Pharmaceuticals SA
  • Okamoto Industries, Inc.
  • Organon & Co.
  • Perrigo Company PLC
  • Pfizer Inc.
  • Piramal Pharma Ltd.
  • Reckitt Benckiser Group PLC
  • Ritex GmbH
  • Sanofi SA
  • Say It With A Condom, LLC
  • Syzygy Healthcare Solutions LLC
  • Teva Pharmaceutical Industries Ltd.
  • TherapeuticsMD, Inc.
  • TTK Healthcare Limited
  • Veru Inc.
  • Viatris Inc.
Product Code: MRR-4316E4E895C4

The Contraceptive Market was valued at USD 38.40 billion in 2024 and is projected to grow to USD 41.13 billion in 2025, with a CAGR of 7.41%, reaching USD 58.98 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 38.40 billion
Estimated Year [2025] USD 41.13 billion
Forecast Year [2030] USD 58.98 billion
CAGR (%) 7.41%

The contraceptive market is witnessing an era of robust innovation and dynamic evolution, driven by advances in science, technology, and shifting consumer preferences. In recent years, market participants have navigated an environment characterized by increasing demand for more effective, convenient, and flexible contraceptive solutions. This transformation is underpinned by evolving healthcare policies, rising awareness regarding reproductive health, and significant investments in research and development. Companies and stakeholders are now adopting strategies that prioritize patient-centric approaches, thereby fostering a landscape where traditional methods are continuously enhanced by transformative breakthroughs.

In this environment, informed decision-making and strategic planning play pivotal roles. The market today is not only determined by technological advancements but also by the socio-economic shifts that influence consumer adoption. As key stakeholders strive to balance innovation with accessibility, the global market continues to expand, offering promising opportunities for growth and collaboration. Analyzing these aspects provides the foundation for understanding the extensive impact of factors shaping the contraceptive industry. This overview sets the stage to discuss more detailed insights, strategic shifts, and segmentation dynamics pivotal to a thorough market analysis.

Transformative Shifts in the Contraceptive Landscape

Recent transformative shifts in the market have redefined how contraception is perceived, developed, and delivered. Innovations in product technology, increased emphasis on individual needs, and breakthroughs in product formulations have all contributed to a shift from conventional methods to more diversified solutions. Key players are now investing in advanced research to optimize dosage formations and improve delivery mechanisms, catering to the need for both long-term reliability and short-term flexibility.

Additionally, regulatory changes and evolving healthcare frameworks have significantly accelerated product development cycles. Enhanced quality control measures and an emphasis on clinical efficacy have bolstered consumer confidence. Market trends indicate a notable pivot towards digital outreach, with online sales channels expanding access to information and products, ultimately leading to improved customer engagement. These dynamic changes are indicative of a market that is no longer stagnant but is constantly embracing innovation. This ongoing evolution is setting the stage for further growth and refinement in product offerings, making it imperative for industry leaders to adapt and pivot their strategies in order to remain competitive in an increasingly dynamic market.

Key Segmentation Insights

Analyzing the market through various segmentation approaches provides invaluable perspectives for understanding consumer behavior and identifying niche opportunities. The market is studied based on type, where the analysis spans the spectrum of Emergency Contraceptives, Hormonal, Non-Hormonal, and Permanent methods. In emergency applications, both IUDs and Pills receive distinct attention, while the hormonal segment is meticulously dissected into Implantable, Injectable, Oral, and Transdermal Contraceptives. Further exploration within the non-hormonal category reveals detailed insights into Barrier Methods, Herbal Contraceptives, and Natural Methods, with the herbal category subdivided into Ayurvedic and Homeopathic approaches. The permanent segment, on the other hand, is characterized by Tubal Ligation and Vasectomy options.

Other dimensions include the formulation of products, which are analyzed in forms such as Patch, Pill, and Ring, with a further investigation into Monophasic and Multiphasic subtypes for pills. By adopting a multi-dimensional perspective, the market is also examined according to mode of action, distinguishing solutions that prevent implantation, enact spermicidal action, or suppress ovulation. Additional insights focus on material type by evaluating Latex-Based and Non-Latex variants; the latter is further studied across Nitrile, Polyisoprene, and Polyurethane. Duration-based segmentation divides products into long-term and short-term solutions, while usage frequency differentiates on-demand solutions from regular use. Sales channels and application scenarios further refine this segmentation, with distribution analyzed through both offline venues including hospital pharmacy and traditional pharmacy, and online platforms such as e-commerce portals and online pharmacies. Lastly, end-user analysis segments the market into female and male demographics, with the female segment further classified by adolescent, adult, and post-menopausal groups, offering a comprehensive outlook on consumer demographics and preferences.

Based on Type, market is studied across Emergency Contraceptives, Hormonal, Non-Hormonal, and Permanent. The Emergency Contraceptives is further studied across IUDs and Pills. The Hormonal is further studied across Implantable Contraceptives, Injectable Contraceptives, Oral Contraceptives, and Transdermal Contraceptives. The Non-Hormonal is further studied across Barrier Methods, Herbal Contraceptives, and Natural Methods. The Herbal Contraceptives is further studied across Ayurvedic and Homeopathic. The Permanent is further studied across Tubal Ligation and Vasectomy.

Based on Formulation, market is studied across Patch, Pill, and Ring. The Pill is further studied across Monophasic and Multiphasic.

Based on Mode Of Action, market is studied across Prevent Implantation, Spermicidal Action, and Suppress Ovulation.

Based on Material Type, market is studied across Latex-Based and Non-Latex. The Non-Latex is further studied across Nitrile, Polyisoprene, and Polyurethane.

Based on Duration, market is studied across Long-Term and Short-Term.

Based on Usage Frequency, market is studied across On-Demand and Regular Use.

Based on Sales Channel, market is studied across Offline and Online. The Offline is further studied across Hospital Pharmacy and Pharmacy. The Online is further studied across E-Commerce Platforms and Online Pharmacy.

Based on Application, market is studied across General Use and Post-Coital Use.

Based on End-User, market is studied across Female and Male. The Female is further studied across Adolescent, Adult, and Post-Menopausal.

Key Regional Insights

Geographic analysis reveals compelling trends that suggest a broad array of opportunities across multiple regions. In the Americas, market growth is supported by a combination of robust healthcare infrastructure and significant investment in pharmaceutical research, driving rapid adoption and diversification of contraceptive products. Regulatory frameworks in this region facilitate easy market entry while also promoting innovation through supportive public health reforms. Similarly, the expansive territory of Europe, the Middle East, and Africa presents a diverse landscape where mature markets coexist with burgeoning economies that are increasingly prioritizing reproductive health. The integration of digital technologies into traditional healthcare systems is fostering a reimagined approach to distribution and customer engagement across these regions.

In addition to these, the Asia-Pacific region emerges as a notable hotspot of growth. Factors such as a rising middle-class population, improved healthcare access, and governmental initiatives aiming to enhance public awareness contribute to an accelerated demand for both conventional and innovative contraceptive solutions. Cross-regional comparisons highlight that while the Americas benefit from strategic investments and established health services, Europe, the Middle East, and Africa are demonstrating agility through policy reforms and market liberalization. The Asia-Pacific, meanwhile, remains a strategic target for expansion given its dynamic consumer base and rapid technological adaptation. These insights collectively underscore the importance of tailoring market strategies to specific regional characteristics in order to optimize reach and impact.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Insights

An analysis of the market is incomplete without a thorough understanding of the influential companies driving growth and innovation. Leading industry players such as Abbvie Inc. have consistently demonstrated a commitment to research excellence and product innovation. Acme Generics Pvt. Ltd. and Afaxys, Inc. contribute significantly to competitive pricing strategies, while firms like Agile Therapeutics, Inc. and Amneal Pharmaceuticals LLC push boundaries in product accessibility. Domestic and international collaborations by ASKA Pharmaceutical Co., Ltd. and Aurobindo Pharma Limited have paved the way for broader market penetration across varied demographics.

Companies including Bayer AG, Church & Dwight Co., Inc., and Cipla Limited continue to invest in market diversification and adaptation to regulatory standards, ensuring that their product pipelines remain robust and responsive to consumer needs. HLL Lifecare Limited and Insud Pharma, S.L. have strategically focused on expanding their geographic presence, while Johnson & Johnson Services, Inc. and Lupin Limited emphasize quality and customer reliability. Global leaders such as Mayne Pharma Group Limited, Merck & Co., Inc., and Mithra Pharmaceuticals S.A. are setting industry benchmarks, with additional insights provided by firms like Okamoto Industries, Inc., Organon & Co., and Perrigo Company PLC. The competitive landscape is further enriched by market powerhouses including Pfizer Inc., Piramal Pharma Ltd., Reckitt Benckiser Group PLC, Ritex GmbH, Sanofi S.A., and emerging innovators like Say It With A Condom, LLC, Syzygy Healthcare Solutions LLC, Teva Pharmaceutical Industries Ltd., TherapeuticsMD, Inc., TTK Healthcare Limited, Veru Inc., and Viatris Inc. collectively shaping the future of the contraceptive market.

The report delves into recent significant developments in the Contraceptive Market, highlighting leading vendors and their innovative profiles. These include Abbvie Inc., Acme Generics Pvt. Ltd., Afaxys, Inc., Agile Therapeutics, Inc., Amneal Pharmaceuticals LLC, ASKA Pharmaceutical Co., Ltd., Aurobindo Pharma Limited, Bayer AG, Church & Dwight Co., Inc., Cipla Limited, HLL Lifecare Limited, Insud Pharma, S.L., Johnson & Johnson Services, Inc., Lupin Limited, Mayne Pharma Group Limited, Merck & Co., Inc., Mithra Pharmaceuticals S.A., Okamoto Industries, Inc., Organon & Co., Perrigo Company PLC, Pfizer Inc., Piramal Pharma Ltd., Reckitt Benckiser Group PLC, Ritex GmbH, Sanofi S.A., Say It With A Condom, LLC, Syzygy Healthcare Solutions LLC, Teva Pharmaceutical Industries Ltd., TherapeuticsMD, Inc., TTK Healthcare Limited, Veru Inc., and Viatris Inc.. Actionable Recommendations for Industry Leaders

Industry leaders are advised to harness the potential of emerging trends and strategic segmentation to secure a competitive advantage in the dynamic contraceptive market. A data-driven approach is paramount-one that harnesses robust market intelligence to identify and prioritize under-served segments. Companies should invest in developing innovative products that align with shifting consumer demographics, particularly by focusing on customer-centric approaches that account for diverse user needs. Emphasizing research and development in both short-term and long-term preventive measures can yield significant market dividends.

Leaders must also nurture strategic partnerships with regulatory bodies and technology innovators to enhance distribution through both traditional and digital sales channels. This dual-channel approach not only broadens market reach but also reinforces supply chain resilience. Additionally, companies should prioritize market education initiatives and targeted communications strategies that demystify product features for end-users. By aligning product development closely with evolving consumer preferences and regulatory mandates, businesses can cultivate enhanced brand loyalty and drive sustained growth. Ultimately, proactive engagement with emerging market trends and thoughtful segmentation strategies will ensure that industry leaders remain positioned at the forefront of this evolving landscape.

Conclusion and Forward-Looking Perspective

A comprehensive review of the contraceptive market reveals a dynamic and rapidly evolving sector, characterized by transformative shifts in technology, consumer behavior, and regional demands. The evolving landscape, driven by innovations and strategic segmentation, underscores the need for an agile approach to market dynamics. Companies that invest in both product innovation and nuanced customer engagement strategies are best positioned to thrive in this competitive environment.

The robust analysis of market segmentation-from type and formulation to mode of action and distribution channels-demonstrates the critical role that tailored strategies play in addressing the diverse needs of a global consumer base. Trends across regions, including the Americas, Europe, the Middle East, Africa, and Asia-Pacific, highlight the varied challenges and opportunities that require localized strategies alongside global best practices. The collective insights serve as a call for industry stakeholders to embrace an iterative process of innovation, compliance, and proactive market repositioning, ensuring sustainable growth in a technology-driven era. In essence, the current market outlook offers a fertile ground for forward-thinking strategies that anticipate future shifts while addressing today's challenges.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing consumer awareness and education around reproductive health and contraceptives
      • 5.1.1.2. Government initiatives and policies promoting the use of contraceptives for population management
      • 5.1.1.3. Technological advancements leading to the development of newer and more effective contraceptive methods
    • 5.1.2. Restraints
      • 5.1.2.1. Barriers encountered in educating and raising awareness around effective contraceptive methods
    • 5.1.3. Opportunities
      • 5.1.3.1. Increased telemedicine facilitates prescription contraceptive accessibility for remote and busy consumers
      • 5.1.3.2. Growing focus on male contraceptives creating new opportunities for product innovation and diversification
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns of personalization and customization in contraceptive solutions to meet diverse needs
      • 5.1.4.2. Addressing societal and cultural stigmas impacting the acceptance and adoption of contraceptives
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type : High inclination toward oral contraceptives due to their efficacy and ease of discontinuation
    • 5.2.2. End-User : Significant adoption of female contraceptives due to availability of a wide range of products
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Contraceptive Market, by Type

  • 6.1. Introduction
  • 6.2. Emergency Contraceptives
    • 6.2.1. IUDs
    • 6.2.2. Pills
  • 6.3. Hormonal
    • 6.3.1. Implantable Contraceptives
    • 6.3.2. Injectable Contraceptives
    • 6.3.3. Oral Contraceptives
    • 6.3.4. Transdermal Contraceptives
  • 6.4. Non-Hormonal
    • 6.4.1. Barrier Methods
    • 6.4.2. Herbal Contraceptives
      • 6.4.2.1. Ayurvedic
      • 6.4.2.2. Homeopathic
    • 6.4.3. Natural Methods
  • 6.5. Permanent
    • 6.5.1. Tubal Ligation
    • 6.5.2. Vasectomy

7. Contraceptive Market, by Formulation

  • 7.1. Introduction
  • 7.2. Patch
  • 7.3. Pill
    • 7.3.1. Monophasic
    • 7.3.2. Multiphasic
  • 7.4. Ring

8. Contraceptive Market, by Mode Of Action

  • 8.1. Introduction
  • 8.2. Prevent Implantation
  • 8.3. Spermicidal Action
  • 8.4. Suppress Ovulation

9. Contraceptive Market, by Material Type

  • 9.1. Introduction
  • 9.2. Latex-Based
  • 9.3. Non-Latex
    • 9.3.1. Nitrile
    • 9.3.2. Polyisoprene
    • 9.3.3. Polyurethane

10. Contraceptive Market, by Duration

  • 10.1. Introduction
  • 10.2. Long-Term
  • 10.3. Short-Term

11. Contraceptive Market, by Usage Frequency

  • 11.1. Introduction
  • 11.2. On-Demand
  • 11.3. Regular Use

12. Contraceptive Market, by Sales Channel

  • 12.1. Introduction
  • 12.2. Offline
    • 12.2.1. Hospital Pharmacy
    • 12.2.2. Pharmacy
  • 12.3. Online
    • 12.3.1. E-Commerce Platforms
    • 12.3.2. Online Pharmacy

13. Contraceptive Market, by Application

  • 13.1. Introduction
  • 13.2. General Use
  • 13.3. Post-Coital Use

14. Contraceptive Market, by End-User

  • 14.1. Introduction
  • 14.2. Female
    • 14.2.1. Adolescent
    • 14.2.2. Adult
    • 14.2.3. Post-Menopausal
  • 14.3. Male

15. Americas Contraceptive Market

  • 15.1. Introduction
  • 15.2. Argentina
  • 15.3. Brazil
  • 15.4. Canada
  • 15.5. Mexico
  • 15.6. United States

16. Asia-Pacific Contraceptive Market

  • 16.1. Introduction
  • 16.2. Australia
  • 16.3. China
  • 16.4. India
  • 16.5. Indonesia
  • 16.6. Japan
  • 16.7. Malaysia
  • 16.8. Philippines
  • 16.9. Singapore
  • 16.10. South Korea
  • 16.11. Taiwan
  • 16.12. Thailand
  • 16.13. Vietnam

17. Europe, Middle East & Africa Contraceptive Market

  • 17.1. Introduction
  • 17.2. Denmark
  • 17.3. Egypt
  • 17.4. Finland
  • 17.5. France
  • 17.6. Germany
  • 17.7. Israel
  • 17.8. Italy
  • 17.9. Netherlands
  • 17.10. Nigeria
  • 17.11. Norway
  • 17.12. Poland
  • 17.13. Qatar
  • 17.14. Russia
  • 17.15. Saudi Arabia
  • 17.16. South Africa
  • 17.17. Spain
  • 17.18. Sweden
  • 17.19. Switzerland
  • 17.20. Turkey
  • 17.21. United Arab Emirates
  • 17.22. United Kingdom

18. Competitive Landscape

  • 18.1. Market Share Analysis, 2024
  • 18.2. FPNV Positioning Matrix, 2024
  • 18.3. Competitive Scenario Analysis
    • 18.3.1. Agile Therapeutics acquisition by Insud Pharma to enhance women's health and contraceptive portfolio
    • 18.3.2. Evofem enhances contraceptive innovation through new Phexxi patent and strategic Aditxt merger
    • 18.3.3. Opill and WNBA collaborates to enhance contraceptive access and women's health equity
    • 18.3.4. Bayer and Dare Bioscience collaborates to innovate Hormone-Free contraceptives
    • 18.3.5. Richmond Biotech Company to buy Contraceptive biz for USD 100 Million
    • 18.3.6. UK Launches First Trial of Hormone-free Male Birth Control pill
    • 18.3.7. Aditxt Acquires Phexxi Contraceptive Gel-Maker Evofem for USD 100 million
    • 18.3.8. Dare Bioscience Launches Phase III Hormone-free Contraceptive Trial
    • 18.3.9. Lupin Launches Turqoz (Norgestrel and Ethinyl Estradiol) Tablets USP in the United States
    • 18.3.10. Bayer and CrossBay Medical to Develop Novel Intrauterine System Inserter
    • 18.3.11. Xiromed LLC Announces Launch of EnilloRing in the United States
    • 18.3.12. Bayer Invests in USD 267.2 Million new Production Facility in Finland to Accelerate Global Access to Modern Contraception
    • 18.3.13. NIH Center Grant Bolsters Male Contraceptive Research
    • 18.3.14. Gates Foundation, Children's Investment Fund Foundation, Pfizer and BD Company Expand Partnership for Greater Access to Injectable Contraceptive for Women
    • 18.3.15. Perrigo Announces U.S. FDA Approval for Opill OTC Daily Oral Contraceptive
    • 18.3.16. FDA Approves First Nonprescription Daily Oral Contraceptive
    • 18.3.17. Sirona Acquires India's First Vegan Condom Brand Bleu
  • 18.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbvie Inc.
  • 2. Acme Generics Pvt. Ltd.
  • 3. Afaxys, Inc.
  • 4. Agile Therapeutics, Inc.
  • 5. Amneal Pharmaceuticals LLC
  • 6. ASKA Pharmaceutical Co., Ltd.
  • 7. Aurobindo Pharma Limited
  • 8. Bayer AG
  • 9. Church & Dwight Co., Inc.
  • 10. Cipla Limited
  • 11. HLL Lifecare Limited
  • 12. Insud Pharma, S.L.
  • 13. Johnson & Johnson Services, Inc.
  • 14. Lupin Limited
  • 15. Mayne Pharma Group Limited
  • 16. Merck & Co., Inc.
  • 17. Mithra Pharmaceuticals S.A.
  • 18. Okamoto Industries, Inc.
  • 19. Organon & Co.
  • 20. Perrigo Company PLC
  • 21. Pfizer Inc.
  • 22. Piramal Pharma Ltd.
  • 23. Reckitt Benckiser Group PLC
  • 24. Ritex GmbH
  • 25. Sanofi S.A.
  • 26. Say It With A Condom, LLC
  • 27. Syzygy Healthcare Solutions LLC
  • 28. Teva Pharmaceutical Industries Ltd.
  • 29. TherapeuticsMD, Inc.
  • 30. TTK Healthcare Limited
  • 31. Veru Inc.
  • 32. Viatris Inc.

LIST OF FIGURES

  • FIGURE 1. CONTRACEPTIVE MARKET MULTI-CURRENCY
  • FIGURE 2. CONTRACEPTIVE MARKET MULTI-LANGUAGE
  • FIGURE 3. CONTRACEPTIVE MARKET RESEARCH PROCESS
  • FIGURE 4. CONTRACEPTIVE MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL CONTRACEPTIVE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL CONTRACEPTIVE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CONTRACEPTIVE MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL CONTRACEPTIVE MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CONTRACEPTIVE MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL CONTRACEPTIVE MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CONTRACEPTIVE MARKET SIZE, BY MODE OF ACTION, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL CONTRACEPTIVE MARKET SIZE, BY MODE OF ACTION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL CONTRACEPTIVE MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL CONTRACEPTIVE MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DURATION, 2024 VS 2030 (%)
  • FIGURE 17. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DURATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. GLOBAL CONTRACEPTIVE MARKET SIZE, BY USAGE FREQUENCY, 2024 VS 2030 (%)
  • FIGURE 19. GLOBAL CONTRACEPTIVE MARKET SIZE, BY USAGE FREQUENCY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. GLOBAL CONTRACEPTIVE MARKET SIZE, BY SALES CHANNEL, 2024 VS 2030 (%)
  • FIGURE 21. GLOBAL CONTRACEPTIVE MARKET SIZE, BY SALES CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. GLOBAL CONTRACEPTIVE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 23. GLOBAL CONTRACEPTIVE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. GLOBAL CONTRACEPTIVE MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
  • FIGURE 25. GLOBAL CONTRACEPTIVE MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 26. AMERICAS CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 27. AMERICAS CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 28. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 29. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 30. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 31. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 32. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 33. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 34. CONTRACEPTIVE MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 35. CONTRACEPTIVE MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. CONTRACEPTIVE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL CONTRACEPTIVE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CONTRACEPTIVE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CONTRACEPTIVE MARKET DYNAMICS
  • TABLE 7. GLOBAL CONTRACEPTIVE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CONTRACEPTIVE MARKET SIZE, BY EMERGENCY CONTRACEPTIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CONTRACEPTIVE MARKET SIZE, BY IUDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CONTRACEPTIVE MARKET SIZE, BY PILLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CONTRACEPTIVE MARKET SIZE, BY EMERGENCY CONTRACEPTIVES, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CONTRACEPTIVE MARKET SIZE, BY HORMONAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CONTRACEPTIVE MARKET SIZE, BY IMPLANTABLE CONTRACEPTIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CONTRACEPTIVE MARKET SIZE, BY INJECTABLE CONTRACEPTIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CONTRACEPTIVE MARKET SIZE, BY ORAL CONTRACEPTIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CONTRACEPTIVE MARKET SIZE, BY TRANSDERMAL CONTRACEPTIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CONTRACEPTIVE MARKET SIZE, BY NON-HORMONAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CONTRACEPTIVE MARKET SIZE, BY BARRIER METHODS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CONTRACEPTIVE MARKET SIZE, BY HERBAL CONTRACEPTIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CONTRACEPTIVE MARKET SIZE, BY AYURVEDIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CONTRACEPTIVE MARKET SIZE, BY HOMEOPATHIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CONTRACEPTIVE MARKET SIZE, BY HERBAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CONTRACEPTIVE MARKET SIZE, BY NATURAL METHODS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CONTRACEPTIVE MARKET SIZE, BY NON-HORMONAL, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CONTRACEPTIVE MARKET SIZE, BY PERMANENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CONTRACEPTIVE MARKET SIZE, BY TUBAL LIGATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CONTRACEPTIVE MARKET SIZE, BY VASECTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL CONTRACEPTIVE MARKET SIZE, BY PERMANENT, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL CONTRACEPTIVE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL CONTRACEPTIVE MARKET SIZE, BY PATCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL CONTRACEPTIVE MARKET SIZE, BY PILL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL CONTRACEPTIVE MARKET SIZE, BY MONOPHASIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL CONTRACEPTIVE MARKET SIZE, BY MULTIPHASIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL CONTRACEPTIVE MARKET SIZE, BY PILL, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL CONTRACEPTIVE MARKET SIZE, BY RING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL CONTRACEPTIVE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL CONTRACEPTIVE MARKET SIZE, BY PREVENT IMPLANTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL CONTRACEPTIVE MARKET SIZE, BY SPERMICIDAL ACTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL CONTRACEPTIVE MARKET SIZE, BY SUPPRESS OVULATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL CONTRACEPTIVE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL CONTRACEPTIVE MARKET SIZE, BY LATEX-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL CONTRACEPTIVE MARKET SIZE, BY NON-LATEX, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL CONTRACEPTIVE MARKET SIZE, BY NITRILE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL CONTRACEPTIVE MARKET SIZE, BY POLYISOPRENE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL CONTRACEPTIVE MARKET SIZE, BY POLYURETHANE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL CONTRACEPTIVE MARKET SIZE, BY NON-LATEX, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DURATION, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL CONTRACEPTIVE MARKET SIZE, BY LONG-TERM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL CONTRACEPTIVE MARKET SIZE, BY SHORT-TERM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL CONTRACEPTIVE MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
  • TABLE 52. GLOBAL CONTRACEPTIVE MARKET SIZE, BY ON-DEMAND, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 53. GLOBAL CONTRACEPTIVE MARKET SIZE, BY REGULAR USE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 54. GLOBAL CONTRACEPTIVE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 55. GLOBAL CONTRACEPTIVE MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 56. GLOBAL CONTRACEPTIVE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 57. GLOBAL CONTRACEPTIVE MARKET SIZE, BY PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 58. GLOBAL CONTRACEPTIVE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 59. GLOBAL CONTRACEPTIVE MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 60. GLOBAL CONTRACEPTIVE MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 61. GLOBAL CONTRACEPTIVE MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 62. GLOBAL CONTRACEPTIVE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
  • TABLE 63. GLOBAL CONTRACEPTIVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. GLOBAL CONTRACEPTIVE MARKET SIZE, BY GENERAL USE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 65. GLOBAL CONTRACEPTIVE MARKET SIZE, BY POST-COITAL USE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 66. GLOBAL CONTRACEPTIVE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. GLOBAL CONTRACEPTIVE MARKET SIZE, BY FEMALE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 68. GLOBAL CONTRACEPTIVE MARKET SIZE, BY ADOLESCENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 69. GLOBAL CONTRACEPTIVE MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 70. GLOBAL CONTRACEPTIVE MARKET SIZE, BY POST-MENOPAUSAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 71. GLOBAL CONTRACEPTIVE MARKET SIZE, BY FEMALE, 2018-2030 (USD MILLION)
  • TABLE 72. GLOBAL CONTRACEPTIVE MARKET SIZE, BY MALE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 73. AMERICAS CONTRACEPTIVE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. AMERICAS CONTRACEPTIVE MARKET SIZE, BY EMERGENCY CONTRACEPTIVES, 2018-2030 (USD MILLION)
  • TABLE 75. AMERICAS CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2030 (USD MILLION)
  • TABLE 76. AMERICAS CONTRACEPTIVE MARKET SIZE, BY NON-HORMONAL, 2018-2030 (USD MILLION)
  • TABLE 77. AMERICAS CONTRACEPTIVE MARKET SIZE, BY HERBAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
  • TABLE 78. AMERICAS CONTRACEPTIVE MARKET SIZE, BY PERMANENT, 2018-2030 (USD MILLION)
  • TABLE 79. AMERICAS CONTRACEPTIVE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 80. AMERICAS CONTRACEPTIVE MARKET SIZE, BY PILL, 2018-2030 (USD MILLION)
  • TABLE 81. AMERICAS CONTRACEPTIVE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 82. AMERICAS CONTRACEPTIVE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. AMERICAS CONTRACEPTIVE MARKET SIZE, BY NON-LATEX, 2018-2030 (USD MILLION)
  • TABLE 84. AMERICAS CONTRACEPTIVE MARKET SIZE, BY DURATION, 2018-2030 (USD MILLION)
  • TABLE 85. AMERICAS CONTRACEPTIVE MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
  • TABLE 86. AMERICAS CONTRACEPTIVE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 87. AMERICAS CONTRACEPTIVE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 88. AMERICAS CONTRACEPTIVE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
  • TABLE 89. AMERICAS CONTRACEPTIVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. AMERICAS CONTRACEPTIVE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. AMERICAS CONTRACEPTIVE MARKET SIZE, BY FEMALE, 2018-2030 (USD MILLION)
  • TABLE 92. AMERICAS CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 93. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY EMERGENCY CONTRACEPTIVES, 2018-2030 (USD MILLION)
  • TABLE 95. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2030 (USD MILLION)
  • TABLE 96. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY NON-HORMONAL, 2018-2030 (USD MILLION)
  • TABLE 97. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY HERBAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
  • TABLE 98. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY PERMANENT, 2018-2030 (USD MILLION)
  • TABLE 99. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 100. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY PILL, 2018-2030 (USD MILLION)
  • TABLE 101. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 102. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY NON-LATEX, 2018-2030 (USD MILLION)
  • TABLE 104. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY DURATION, 2018-2030 (USD MILLION)
  • TABLE 105. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
  • TABLE 106. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 107. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 108. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
  • TABLE 109. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY FEMALE, 2018-2030 (USD MILLION)
  • TABLE 112. BRAZIL CONTRACEPTIVE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. BRAZIL CONTRACEPTIVE MARKET SIZE, BY EMERGENCY CONTRACEPTIVES, 2018-2030 (USD MILLION)
  • TABLE 114. BRAZIL CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2030 (USD MILLION)
  • TABLE 115. BRAZIL CONTRACEPTIVE MARKET SIZE, BY NON-HORMONAL, 2018-2030 (USD MILLION)
  • TABLE 116. BRAZIL CONTRACEPTIVE MARKET SIZE, BY HERBAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
  • TABLE 117. BRAZIL CONTRACEPTIVE MARKET SIZE, BY PERMANENT, 2018-2030 (USD MILLION)
  • TABLE 118. BRAZIL CONTRACEPTIVE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 119. BRAZIL CONTRACEPTIVE MARKET SIZE, BY PILL, 2018-2030 (USD MILLION)
  • TABLE 120. BRAZIL CONTRACEPTIVE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 121. BRAZIL CONTRACEPTIVE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. BRAZIL CONTRACEPTIVE MARKET SIZE, BY NON-LATEX, 2018-2030 (USD MILLION)
  • TABLE 123. BRAZIL CONTRACEPTIVE MARKET SIZE, BY DURATION, 2018-2030 (USD MILLION)
  • TABLE 124. BRAZIL CONTRACEPTIVE MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
  • TABLE 125. BRAZIL CONTRACEPTIVE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 126. BRAZIL CONTRACEPTIVE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 127. BRAZIL CONTRACEPTIVE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
  • TABLE 128. BRAZIL CONTRACEPTIVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. BRAZIL CONTRACEPTIVE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. BRAZIL CONTRACEPTIVE MARKET SIZE, BY FEMALE, 2018-2030 (USD MILLION)
  • TABLE 131. CANADA CONTRACEPTIVE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. CANADA CONTRACEPTIVE MARKET SIZE, BY EMERGENCY CONTRACEPTIVES, 2018-2030 (USD MILLION)
  • TABLE 133. CANADA CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2030 (USD MILLION)
  • TABLE 134. CANADA CONTRACEPTIVE MARKET SIZE, BY NON-HORMONAL, 2018-2030 (USD MILLION)
  • TABLE 135. CANADA CONTRACEPTIVE MARKET SIZE, BY HERBAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
  • TABLE 136. CANADA CONTRACEPTIVE MARKET SIZE, BY PERMANENT, 2018-2030 (USD MILLION)
  • TABLE 137. CANADA CONTRACEPTIVE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 138. CANADA CONTRACEPTIVE MARKET SIZE, BY PILL, 2018-2030 (USD MILLION)
  • TABLE 139. CANADA CONTRACEPTIVE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 140. CANADA CONTRACEPTIVE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. CANADA CONTRACEPTIVE MARKET SIZE, BY NON-LATEX, 2018-2030 (USD MILLION)
  • TABLE 142. CANADA CONTRACEPTIVE MARKET SIZE, BY DURATION, 2018-2030 (USD MILLION)
  • TABLE 143. CANADA CONTRACEPTIVE MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
  • TABLE 144. CANADA CONTRACEPTIVE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 145. CANADA CONTRACEPTIVE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 146. CANADA CONTRACEPTIVE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
  • TABLE 147. CANADA CONTRACEPTIVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. CANADA CONTRACEPTIVE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. CANADA CONTRACEPTIVE MARKET SIZE, BY FEMALE, 2018-2030 (USD MILLION)
  • TABLE 150. MEXICO CONTRACEPTIVE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. MEXICO CONTRACEPTIVE MARKET SIZE, BY EMERGENCY CONTRACEPTIVES, 2018-2030 (USD MILLION)
  • TABLE 152. MEXICO CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2030 (USD MILLION)
  • TABLE 153. MEXICO CONTRACEPTIVE MARKET SIZE, BY NON-HORMONAL, 2018-2030 (USD MILLION)
  • TABLE 154. MEXICO CONTRACEPTIVE MARKET SIZE, BY HERBAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
  • TABLE 155. MEXICO CONTRACEPTIVE MARKET SIZE, BY PERMANENT, 2018-2030 (USD MILLION)
  • TABLE 156. MEXICO CONTRACEPTIVE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 157. MEXICO CONTRACEPTIVE MARKET SIZE, BY PILL, 2018-2030 (USD MILLION)
  • TABLE 158. MEXICO CONTRACEPTIVE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 159. MEXICO CONTRACEPTIVE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. MEXICO CONTRACEPTIVE MARKET SIZE, BY NON-LATEX, 2018-2030 (USD MILLION)
  • TABLE 161. MEXICO CONTRACEPTIVE MARKET SIZE, BY DURATION, 2018-2030 (USD MILLION)
  • TABLE 162. MEXICO CONTRACEPTIVE MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
  • TABLE 163. MEXICO CONTRACEPTIVE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 164. MEXICO CONTRACEPTIVE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 165. MEXICO CONTRACEPTIVE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
  • TABLE 166. MEXICO CONTRACEPTIVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. MEXICO CONTRACEPTIVE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. MEXICO CONTRACEPTIVE MARKET SIZE, BY FEMALE, 2018-2030 (USD MILLION)
  • TABLE 169. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY EMERGENCY CONTRACEPTIVES, 2018-2030 (USD MILLION)
  • TABLE 171. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2030 (USD MILLION)
  • TABLE 172. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY NON-HORMONAL, 2018-2030 (USD MILLION)
  • TABLE 173. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY HERBAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
  • TABLE 174. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY PERMANENT, 2018-2030 (USD MILLION)
  • TABLE 175. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 176. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY PILL, 2018-2030 (USD MILLION)
  • TABLE 177. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 178. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY NON-LATEX, 2018-2030 (USD MILLION)
  • TABLE 180. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY DURATION, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY FEMALE, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY EMERGENCY CONTRACEPTIVES, 2018-2030 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2030 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY NON-HORMONAL, 2018-2030 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY HERBAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY PERMANENT, 2018-2030 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY PILL, 2018-2030 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY NON-LATEX, 2018-2030 (USD MILLION)
  • TABLE 200. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY DURATION, 2018-2030 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 203. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 204. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
  • TABLE 205. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 206. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 207. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY FEMALE, 2018-2030 (USD MILLION)
  • TABLE 208. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 209. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY EMERGENCY CONTRACEPTIVES, 2018-2030 (USD MILLION)
  • TABLE 211. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2030 (USD MILLION)
  • TABLE 212. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY NON-HORMONAL, 2018-2030 (USD MILLION)
  • TABLE 213. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY HERBAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
  • TABLE 214. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY PERMANENT, 2018-2030 (USD MILLION)
  • TABLE 215. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 216. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY PILL, 2018-2030 (USD MILLION)
  • TABLE 217. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 218. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY NON-LATEX, 2018-2030 (USD MILLION)
  • TABLE 220. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY DURATION, 2018-2030 (USD MILLION)
  • TABLE 221. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
  • TABLE 222. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 223. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 224. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
  • TABLE 225. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 226. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 227. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY FEMALE, 2018-2030 (USD MILLION)
  • TABLE 228. CHINA CONTRACEPTIVE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. CHINA CONTRACEPTIVE MARKET SIZE, BY EMERGENCY CONTRACEPTIVES, 2018-2030 (USD MILLION)
  • TABLE 230. CHINA CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2030 (USD MILLION)
  • TABLE 231. CHINA CONTRACEPTIVE MARKET SIZE, BY NON-HORMONAL, 2018-2030 (USD MILLION)
  • TABLE 232. CHINA CONTRACEPTIVE MARKET SIZE, BY HERBAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
  • TABLE 233. CHINA CONTRACEPTIVE MARKET SIZE, BY PERMANENT, 2018-2030 (USD MILLION)
  • TABLE 234. CHINA CONTRACEPTIVE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 235. CHINA CONTRACEPTIVE MARKET SIZE, BY PILL, 2018-2030 (USD MILLION)
  • TABLE 236. CHINA CONTRACEPTIVE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 237. CHINA CONTRACEPTIVE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 238. CHINA CONTRACEPTIVE MARKET SIZE, BY NON-LATEX, 2018-2030 (USD MILLION)
  • TABLE 239. CHINA CONTRACEPTIVE MARKET SIZE, BY DURATION, 2018-2030 (USD MILLION)
  • TABLE 240. CHINA CONTRACEPTIVE MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
  • TABLE 241. CHINA CONTRACEPTIVE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 242. CHINA CONTRACEPTIVE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 243. CHINA CONTRACEPTIVE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
  • TABLE 244. CHINA CONTRACEPTIVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 245. CHINA CONTRACEPTIVE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 246. CHINA CONTRACEPTIVE MARKET SIZE, BY FEMALE, 2018-2030 (USD MILLION)
  • TABLE 247. INDIA CONTRACEPTIVE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 248. INDIA CONTRACEPTIVE MARKET SIZE, BY EMERGENCY CONTRACEPTIVES, 2018-2030 (USD MILLION)
  • TABLE 249. INDIA CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2030 (USD MILLION)
  • TABLE 250. INDIA CONTRACEPTIVE MARKET SIZE, BY NON-HORMONAL, 2018-2030 (USD MILLION)
  • TABLE 251. INDIA CONTRACEPTIVE MARKET SIZE, BY HERBAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
  • TABLE 252. INDIA CONTRACEPTIVE MARKET SIZE, BY PERMANENT, 2018-2030 (USD MILLION)
  • TABLE 253. INDIA CONTRACEPTIVE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 254. INDIA CONTRACEPTIVE MARKET SIZE, BY PILL, 2018-2030 (USD MILLION)
  • TABLE 255. INDIA CONTRACEPTIVE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 256. INDIA CONTRACEPTIVE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 257. INDIA CONTRACEPTIVE MARKET SIZE, BY NON-LATEX, 2018-2030 (USD MILLION)
  • TABLE 258. INDIA CONTRACEPTIVE MARKET SIZE, BY DURATION, 2018-2030 (USD MILLION)
  • TABLE 259. INDIA CONTRACEPTIVE MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
  • TABLE 260. INDIA CONTRACEPTIVE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 261. INDIA CONTRACEPTIVE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 262. INDIA CONTRACEPTIVE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
  • TABLE 263. INDIA CONTRACEPTIVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 264. INDIA CONTRACEPTIVE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 265. INDIA CONTRACEPTIVE MARKET SIZE, BY FEMALE, 2018-2030 (USD MILLION)
  • TABLE 266. INDONESIA CONTRACEPTIVE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 267. INDONESIA CONTRACEPTIVE MARKET SIZE, BY EMERGENCY CONTRACEPTIVES, 2018-2030 (USD MILLION)
  • TABLE 268. INDONESIA CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2030 (USD MILLION)
  • TABLE 269. INDONESIA CONTRACEPTIVE MARKET SIZE, BY NON-HORMONAL, 2018-2030 (USD MILLION)
  • TABLE 270. INDONESIA CONTRACEPTIVE MARKET SIZE, BY HERBAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
  • TABLE 271. INDONESIA CONTRACEPTIVE MARKET SIZE, BY PERMANENT, 2018-2030 (USD MILLION)
  • TABLE 272. INDONESIA CONTRACEPTIVE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 273. INDONESIA CONTRACEPTIVE MARKET SIZE, BY PILL, 2018-2030 (USD MILLION)
  • TABLE 274. INDONESIA CONTRACEPTIVE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 275. INDONESIA CONTRACEPTIVE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 276. INDONESIA CONTRACEPTIVE MARKET SIZE, BY NON-LATEX, 2018-2030 (USD MILLION)
  • TABLE 277. INDONESIA CONTRACEPTIVE MARKET SIZE, BY DURATION, 2018-2030 (USD MILLION)
  • TABLE 278. INDONESIA CONTRACEPTIVE MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
  • TABLE 279. INDONESIA CONTRACEPTIVE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 280. INDONESIA CONTRACEPTIVE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 281. INDONESIA CONTRACEPTIVE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
  • TABLE 282. INDONESIA CONTRACEPTIVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 283. INDONESIA CONTRACEPTIVE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 284. INDONESIA CONTRACEPTIVE MARKET SIZE, BY FEMALE, 2018-2030 (USD MILLION)
  • TABLE 285. JAPAN CONTRACEPTIVE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 286. JAPAN CONTRACEPTIVE MARKET SIZE, BY EMERGENCY CONTRACEPTIVES, 2018-2030 (USD MILLION)
  • TABLE 287. JAPAN CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2030 (USD MILLION)
  • TABLE 288. JAPAN CONTRACEPTIVE MARKET SIZE, BY NON-HORMONAL, 2018-2030 (USD MILLION)
  • TABLE 289. JAPAN CONTRACEPTIVE MARKET SIZE, BY HERBAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
  • TABLE 290. JAPAN CONTRACEPTIVE MARKET SIZE, BY PERMANENT, 2018-2030 (USD MILLION)
  • TABLE 291. JAPAN CONTRACEPTIVE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 292. JAPAN CONTRACEPTIVE MARKET SIZE, BY PILL, 2018-2030 (USD MILLION)
  • TABLE 293. JAPAN CONTRACEPTIVE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 294. JAPAN CONTRACEPTIVE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 295. JAPAN CONTRACEPTIVE MARKET SIZE, BY NON-LATEX, 2018-2030 (USD MILLION)
  • TABLE 296. JAPAN CONTRACEPTIVE MARKET SIZE, BY DURATION, 2018-2030 (USD MILLION)
  • TABLE 297. JAPAN CONTRACEPTIVE MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
  • TABLE 298. JAPAN CONTRACEPTIVE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 299. JAPAN CONTRACEPTIVE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 300. JAPAN CONTRACEPTIVE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
  • TABLE 301. JAPAN CONTRACEPTIVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 302. JAPAN CONTRACEPTIVE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 303. JAPAN CONTRACEPTIVE MARKET SIZE, BY FEMALE, 2018-2030 (USD MILLION)
  • TABLE 304. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 305. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY EMERGENCY CONTRACEPTIVES, 2018-2030 (USD MILLION)
  • TABLE 306. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2030 (USD MILLION)
  • TABLE 307. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY NON-HORMONAL, 2018-2030 (USD MILLION)
  • TABLE 308. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY HERBAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
  • TABLE 309. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY PERMANENT, 2018-2030 (USD MILLION)
  • TABLE 310. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 311. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY PILL, 2018-2030 (USD MILLION)
  • TABLE 312. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 313. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 314. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY NON-LATEX, 2018-2030 (USD MILLION)
  • TABLE 315. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY DURATION, 2018-2030 (USD MILLION)
  • TABLE 316. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
  • TABLE 317. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 318. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 319. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
  • TABLE 320. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 321. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 322. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY FEMALE, 2018-2030 (USD MILLION)
  • TABLE 323. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 324. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY EMERGENCY CONTRACEPTIVES, 2018-2030 (USD MILLION)
  • TABLE 325. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2030 (USD MILLION)
  • TABLE 326. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY NON-HORMONAL, 2018-2030 (USD MILLION)
  • TABLE 327. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY HERBAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
  • TABLE 328. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY PERMANENT, 2018-2030 (USD MILLION)
  • TABLE 329. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 330. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY PILL, 2018-2030 (USD MILLION)
  • TABLE 331. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 332. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 333. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY NON-LATEX, 2018-2030 (USD MILLION)
  • TABLE 334. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY DURATION, 2018-2030 (USD MILLION)
  • TABLE 335. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
  • TABLE 336. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 337. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 338. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
  • TABLE 339. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 340. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 341. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY FEMALE, 2018-2030 (USD MILLION)
  • TABLE 342. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 343. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY EMERGENCY CONTRACEPTIVES, 2018-2030 (USD MILLION)
  • TABLE 344. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2030 (USD MILLION)
  • TABLE 345. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY NON-HORMONAL, 2018-2030 (USD MILLION)
  • TABLE 346. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY HERBAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
  • TABLE 347. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY PERMANENT, 2018-2030 (USD MILLION)
  • TABLE 348. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 349. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY PILL, 2018-2030 (USD MILLION)
  • TABLE 350. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 351. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 352. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY NON-LATEX, 2018-2030 (USD MILLION)
  • TABLE 353. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY DURATION, 2018-2030 (USD MILLION)
  • TABLE 354. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
  • TABLE 355. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 356. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 357. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
  • TABLE 358. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 359. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 360. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY FEMALE, 2018-2030 (USD MILLION)
  • TABLE 361. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 362. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY EMERGENCY CONTRACEPTIVES, 2018-2030 (USD MILLION)
  • TABLE 363. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2030 (USD MILLION)
  • TABLE 364. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY NON-HORMONAL, 2018-2030 (USD MILLION)
  • TABLE 365. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY HERBAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
  • TABLE 366. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY PERMANENT, 2018-2030 (USD MILLION)
  • TABLE 367. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 368. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY PILL, 2018-2030 (USD MILLION)
  • TABLE 369. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 370. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 371. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY NON-LATEX, 2018-2030 (USD MILLION)
  • TABLE 372. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY DURATION, 2018-2030 (USD MILLION)
  • TABLE 373. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
  • TABLE 374. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 375. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY OFFLINE, 2